StemCell Institute Inc. (TYO:7096)
Japan
· Delayed Price · Currency is JPY 911.00
-34.00 (-3.60%)
Jul 7, 2025, 3:30 PM JST
StemCell Institute Market Cap
StemCell Institute has a market cap or net worth of 9.68 billion as of July 7, 2025. Its market cap has decreased by -43.62% in one year.
Market Cap
9.68B
Enterprise Value
7.00B
Revenue
2.68B
Ranking
n/a
PE Ratio
25.14
Stock Price
911.00
Market Cap Chart
Since June 25, 2021, StemCell Institute's market cap has decreased from 21.16B to 9.68B, a decrease of -54.24%. That is a compound annual growth rate of -17.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 4, 2025 | 9.68B | -26.69% |
| Dec 30, 2024 | 13.21B | -39.88% |
| Dec 29, 2023 | 21.97B | -17.47% |
| Dec 30, 2022 | 26.62B | 9.16% |
| Dec 30, 2021 | 24.39B | 15.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 11.58T |
| Takeda Pharmaceutical Company | 6,934.56B |
| Daiichi Sankyo Company | 6,021.82B |
| HOYA Corporation | 5,701.79B |
| Terumo | 3,637.23B |
| Otsuka Holdings | 3,600.78B |
| Astellas Pharma | 2,490.93B |
| Shionogi & | 2,132.24B |